• Home
• Defective Drug Index
• About A Drug Recall
• Contact A Defective Drug Lawyer

We Can Help.

Paxil® Suicide

800-250-7280

Paxil® suicide is a major risk for anyone who is currently taking this medication or has recently terminated their Paxil® treatment. Paxil® is a selective serotonin reuptake inhibitor (SSRI) antidepressant prescription drug that was developed by British pharmaceutical giant GlaxoSmithKline. Paxil® was approved by the FDA in 1993 to treat major depression, social anxiety, obsessive compulsive disorder, post traumatic stress disorder, general anxiety, and panic disorder. Paxil® has never been approved for pediatric populations.

Since this drug was approved for use in the United States, hundreds of reports of Paxil® suicide attempts and actual suicides have surfaced in patient cases all over the world. There have been several studies that have found that Paxil® suicide risks are double, or even quadruple, for patients taking this medication. Despite a growing body of evidence which suggests that Paxil® is unsafe for adults and children, the FDA and GlaxoSmithKline consistently adhere to the false claim their Paxil® suicide risks are not significant enough to warrant action that would protect consumers.

A British Paxil® suicide study conducted in 2004 found that patients taking Paxil® were four times more likely to develop Paxil® suicide behaviors compared to trial participants who had not taken this dangerous SSRI antidepressant. Researchers found that a patient's Paxil® suicide risks are greatest within the first week to ten days of treatment and again when a patient terminates their treatment.

Several Paxil® suicide studies have found that Paxil® suicide risks are greatest for children who take this prescription drug. A GlaxoSmithKline sponsored clinical trial found that children who began Paxil® treatment often went through "hellish ordeals of out of control behavior, suicide threats, hallucinations, and hospitalization." The FDA has stated that more than 110 American children have already committed a successful Paxil® suicide attempt.

In one FDA Paxil® suicide investigation, researchers found at least four hundred cases of adverse side effects suffered by children who have taken Paxil®. It is estimated that twenty to forty percent of all Paxil® patients experience side effects that are significant enough to terminate treatment. Because of the high risk of Paxil® suicide in pediatric populations, the British government has ordered doctors to stop prescribing Paxil® to children, though the FDA has not followed suit.

If you or a loved one is taking Paxil® and you are concerned about Paxil® suicide risks, it is important to speak with a doctor before making any treatment changes. Because of the addictive nature of this drug, Paxil® suicide risks can actually increase as a patient attempts to go off this medication. If you witness any signs or symptoms of Paxil® suicide behaviors in yourself or someone you know, it is important to speak to a medical professional.

If you or a loved one has suffered Paxil® suicide ideations or behaviors, please contact us to speak with a qualified and professional attorney who can help protect and maximize your interests.

More Paxil® Resources

Paxil.com -  The official Paxil site from SmithKline Beecham. Discussion of panic disorder, depression, OCD, and social anxiety disorder.